CAS 135721-56-1
:MDL 29,913
Description:
MDL 29,913, also known by its CAS number 135721-56-1, is a chemical compound that belongs to the class of selective serotonin reuptake inhibitors (SSRIs). It is primarily researched for its potential use in treating various mood disorders, including depression and anxiety. The compound exhibits a mechanism of action that involves the inhibition of serotonin reuptake, thereby increasing serotonin levels in the synaptic cleft and enhancing mood regulation. MDL 29,913 is characterized by its specific binding affinity to serotonin transporters, which is crucial for its therapeutic effects. Additionally, it may possess a favorable pharmacokinetic profile, contributing to its efficacy and safety in clinical applications. As with many compounds in this class, potential side effects and interactions with other medications are important considerations in its use. Ongoing research continues to explore its full therapeutic potential and the underlying biochemical pathways it influences.
Formula:C40H56N8O6
InChI:InChI=1/C40H56N8O6/c1-25(2)19-29(41)24-48(5)35(20-26(3)4)40(54)45-32(15-16-36(42)50)38(52)47-34(22-28-23-44-31-14-10-9-13-30(28)31)39(53)46-33(37(51)43-17-18-49)21-27-11-7-6-8-12-27/h6-14,17-18,23,25-26,29,32-35,44H,15-16,19-22,24,41H2,1-5H3,(H2,42,50)(H,45,54)(H,46,53)(H,47,52)/b43-17-/t29?,32-,33-,34-,35-/m0/s1
SMILES:CC(C)CC(CN(C)[C@@H](CC(C)C)C(=N[C@@H](CCC(=N)O)C(=N[C@@H](Cc1c[nH]c2ccccc12)C(=N[C@@H](Cc1ccccc1)C(=O)/N=C\C=O)O)O)O)N
Synonyms:- M.W. 744.93 C40H56N8O6
- N-(2-amino-4-methylpentyl)-N-methyl-L-leucyl-L-glutaminyl-L-tryptophyl-(Z)-N-(2-oxoethylidene)-L-phenylalaninamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
MDL 29913
CAS:NK2 tachykinin receptor selective antagonist.Formula:C40H56N8O6Purity:98%Color and Shape:SolidMolecular weight:745MDL 29913
CAS:MDL 29913 is a potent and selective antagonist of the neurokinin-1 receptor that blocks the action of substance P. It has been shown to reduce both spontaneous activity and maximal response in the bladder, with no effect on blood pressure, when administered at high doses. MDL 29913 has been shown to bind to the high affinity binding site for substance P in homogenates of rat bladder and lung tissue. The functional studies have demonstrated that MDL 29913 can block the functions of substance P in both bladder and lung tissue. This drug has also been shown to be a potent antagonist at this site, inhibiting the responses induced by senktide (a substance P analogue).Formula:C40H56N8O6Purity:Min. 95%Molecular weight:744.92 g/mol

